[
  {
    "ts": "2026-01-02T07:00:00+00:00",
    "headline": "Samsung Bioepis Begins Commercialization of BYOOVIZ速, Biosimilar to Lucentis (Ranibizumab), in Europe",
    "summary": "INCHEON, Korea, January 02, 2026--Samsung Bioepis announced that the company has begun direct commercialization of BYOOVIZ速, a biosimilar to Lucentis (ranibizumab), in Europe.",
    "url": "https://finance.yahoo.com/news/samsung-bioepis-begins-commercialization-byooviz-070000025.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2f74a505-a62a-35b8-a73e-b08a2a1fc3e3",
      "content": {
        "id": "2f74a505-a62a-35b8-a73e-b08a2a1fc3e3",
        "contentType": "STORY",
        "title": "Samsung Bioepis Begins Commercialization of BYOOVIZ速, Biosimilar to Lucentis (Ranibizumab), in Europe",
        "description": "",
        "summary": "INCHEON, Korea, January 02, 2026--Samsung Bioepis announced that the company has begun direct commercialization of BYOOVIZ速, a biosimilar to Lucentis (ranibizumab), in Europe.",
        "pubDate": "2026-01-02T07:00:00Z",
        "displayTime": "2026-01-02T07:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/17900ff8ab97fe67d1730b50a68da90e",
          "originalWidth": 1270,
          "originalHeight": 458,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Df4p_4DQ5s1yZ85Hhw7wNw--~B/aD00NTg7dz0xMjcwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/17900ff8ab97fe67d1730b50a68da90e.cf.webp",
              "width": 1270,
              "height": 458,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mNGsdIzI6RK3dZkGjx4F1g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/17900ff8ab97fe67d1730b50a68da90e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/samsung-bioepis-begins-commercialization-byooviz-070000025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/samsung-bioepis-begins-commercialization-byooviz-070000025.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]